Cambridge Healthtech SCOPE (Summit for Clinical OPS) Attendees Masterfile Email

The Cambridge Healthtech Institute SCOPE (Summit for Clinical OPS Executives) Attendee Masterfile enables you to reach executives from leading Pharma, CRO and Biotech companies. This audience may be targeted by postal, email and online display.

3,127 Total Universe / Universe Rate $1,800.00/F
3,127 U.S. Email Addresses $1,800.00/F
10,419 Postal Subscribers $195.00/M


The SCOPE (Summit for Clinical OPS Executives) Attendee Masterfile is comprised of executives from leading Pharma, CRO and Biotech companies. Industry leaders and key decision makers representing 19 different countries and more than 518 unique organizations convene to share case studies, collaborate on best practices and provide unique perspectives on poignant issues facing Clinical OPS. Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people.


These professionals are focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Lab Services, Precision Medicine and Biomarker-Driven Trials.

Professionals in the SCOPE (Summit for Clinical OPS Executives) Attendee Masterfile are receptive to marketing offers from retailers, government agencies, software developers, IT service providers, tradeshow coordinators, industry publications, financial institutions, robotics developers, medical suppliers, pharmaceuticals, and continuing education providers.


Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.  They report on innovative technologies from clinical trials to medical informatics and cover the application of informatics, IT and computer science in biomedical research and drug discovery.


Conferences include:  The Molecular Medicine Tri-Conference, Bio-IT World, PepTalk (The Protein Science Week), PEGS Summit (Protein and Antibody Engineering Summit), Biomarkers & Diagnostics World Congress, Drug Discovery Chemistry, The Bioprocessing Summit, Discovery on Target, Next Generation Dx Summit, SCOPE (Summit for Clinical Ops Executives) and World Preclinical Congress.

State $15.00/M
SCF $15.00/M
Zip $15.00/M
HTML Setup $150.00/F
Suppression $150.00/F


Job Function   (20.00/M)
Director 	1,102 	
Executive 	799 	
Manager 	680 	
Scientist/Technologist 	474 	

Primary Business   (20.00/M)
Biotechnical 	721 	
CRO 	746 	
Pharmaceutical-Big 	695 	

Ordering Instructions

  • 4,424 Name Minimum Order $0.00 Minimum Price
  • Net Name is not allowed
  • Please Inquire about Exchange
  • Broker Commission 20% on base
  • Please Inquire about Reuse
  • Cancellation fee at $250.00/F: Orders cancelled prior to merge are subject to a $250/F cancellation fee plus any applicable production charges. Orders cancelled after merge purge are payable on full.